Ligue Contre Le Cancer
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for Ligue Contre Le Cancer based on listed parameters only.
The articles listed below published by authors from Ligue Contre Le Cancer, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
| Journal | Count | Share |
|---|---|---|
|
Advanced Materials |
1 | 0.24 |
|
American Journal of Human Genetics |
1 | 0.26 |
|
Arthritis & Rheumatology |
1 | 0.02 |
|
Blood |
1 | 0.03 |
|
Cancer Cell |
1 | 0.03 |
|
Cancer Research |
2 | 0.30 |
|
Cell Stem Cell |
1 | 0.02 |
|
Developmental Cell |
1 | 0.04 |
|
Immunity |
1 | 0.02 |
|
Journal of Biological Chemistry |
1 | 0.08 |
|
Journal of Cell Biology |
1 | 0.00 |
|
Journal of Clinical Oncology |
1 | 0.05 |
|
Journal of Experimental Medicine |
1 | 0.09 |
|
Journal of Neuroscience |
1 | 0.02 |
|
Journal of Physiology |
1 | 0.01 |
|
Journal of the National Cancer Institute |
1 | 0.08 |
|
Molecular Cell |
1 | 0.30 |
|
Nature |
4 | 0.35 |
|
Nature Communications |
12 | 0.94 |
|
Nature Genetics |
1 | 0.03 |
|
Nature Immunology |
1 | 0.02 |
|
Nature Medicine |
1 | 0.01 |
|
Nature Structural & Molecular Biology |
2 | 0.50 |
|
PLOS Biology |
1 | 0.14 |
|
Proceedings of the National Academy of Sciences of the United States of America |
3 | 0.55 |
|
Science |
1 | 0.01 |
|
Science Advances |
3 | 0.47 |
|
Science Translational Medicine |
1 | 0.03 |
|
The EMBO Journal |
4 | 0.75 |
|
The Journal of Allergy and Clinical Immunology |
1 | 0.38 |
|
The Lancet Oncology |
1 | 0.06 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.